stockrowBrainsway Ltd. Sponsored ADR
BWAY Healthcare Medical Devices
Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024.
- Revenue
- +35.4%
- EPS
- +40.0%
- Free cash flow
- −51.7%
Quarter to June 2026, against a year earlier
Follow BWAY
Alert me
Brainsway Ltd. Sponsored ADR (BWAY) EV/Sales
As of 5 November 2026, Brainsway Ltd. Sponsored ADR (BWAY) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from −0.7× (March 2023) to 8.0× (January 2026); the current reading is higher than 41% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.2× | (3.99%) |
| FY2024 | 2.3× | (5.13%) |
| FY2023 | 2.4× | — |
| FY2022 | −0.3× | — |
| FY2021 | 2.2× | (30.78%) |
| FY2020 | 3.2× | (8.99%) |
| FY2019 | 3.5× | (31.03%) |
| FY2018 | 5.1× | 0.00% |
| FY2017 | 5.1× | 0.00% |
| FY2016 | 5.1× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.9× | 13.00% |
| Mar 2026 | 3.5× | 59.81% |
| Dec 2025 | 2.2× | (52.51%) |
| Sep 2025 | 4.6× | 11.01% |
| 31 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OFIX ORTHOFIX MEDICAL INC. compare | 0.6× |
| CERS Cerus Corporation compare | 1.7× |
| BWAY Brainsway Ltd. Sponsored ADR | 2.4× |
| NPCE NeuroPace, Inc. compare | 4.5× |
| MASS 908 Devices Inc. compare | 4.9× |
| SI Shoulder Innovations, Inc. compare | 5.4× |
| RCEL Avita Medical Inc. compare | 6.7× |
| SSII SS Innovations International, Inc. compare | 7.1× |
| SENS Senseonics Holdings, Inc. compare | 8.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)